Robert Weil, MD

216.636.0007

Robert Weil, MD
Department: CCHS Administration
President
Location: Lakewood Hospital
Mail Code ND40
14519 Detroit Avenue
Lakewood, OH 44107
WorkAppointment:216.636.0007
DeskDesk:216.444.2007
Robert Weil, MD
Department: Brain Tumor and Neuro-Oncology Center
Location: Cleveland Clinic Main Campus
Mail Code ND40
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.636.0007
DeskDesk:216.444.2007
Robert Weil, MD
Department: Neurological Surgery
Location: Cleveland Clinic Main Campus
Mail Code ND40
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.636.0007
DeskDesk:216.444.2007
Robert Weil, MD
Department: Taussig Cancer Institute
Location: Cleveland Clinic Main Campus
Mail Code ND40
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.636.0007
DeskDesk:216.444.2007
Surgeon:
No
Treats:
Adults Only

Professional Highlights

  • Melvin Burkhardt Chair in Brain Tumor Research
  • Board-Certified, American Board of Neurological Surgery

Education & Fellowships

Residency - University of Pennsylvania School of Medicine
Neurosurgery
Philadelphia, PA USA
1999
Fellowship - University of Pennsylvania School of Medicine
Research
Philadelphia, PA USA
1993
Residency - University of Chicago Hospitals
Otolaryngology
Chicago, IL USA
1991
Internship - University of Chicago Hospitals
General Surgery
Chicago, IL USA
1989
Medical School - University of Missouri School of Medicine
Columbia, MO USA
1988
Undergraduate - Yale University
History
New Haven, CT USA
1983

Certifications

  • Neurological Surgery

Specialty Interests

Brain tumor, gamma knife

Awards & Honors

Fellow, American College of Surgeons

Treatment & Services

  • Brain Biopsy
  • Brain Tumor Diagnosis
  • Brain Tumor Management
  • Brain Tumor Surgery
  • Clinical Trials
  • Cranial Radiosurgery
  • Craniotomy for Brain Tumor
  • Endoscopic Pituitary Surgery
  • Gamma Knife Radiosurgery
  • Gamma Knife Treatment
  • Lumbar Puncture (Spinal Tap)
  • Minimally Invasive Surgery
  • Neurological Surgery
  • Neurosurgery
  • Stereotactic Brain Biopsy
  • Stereotactic Radiosurgery
  • Stereotactic Surgery
  • Transsphenoidal Pituitary Surgery

Specialty in Diseases and Conditions

  • Adult Brain Tumors
  • Anaplastic Astrocytomas
  • Anaplastic Oligodendrogliomas
  • Astrocytoma
  • Benign Brain Tumors
  • Benign Tumors of the Brain
  • Benign Tumors of the Spinal Cord
  • Brain Cancer (Brain Tumor)
  • Brain Lymphoma
  • Brain Metastases
  • Ependymomas
  • Glioblastoma Multiforme
  • Laboratory Research of Brain Tumors
  • Malignant Gliomas
  • Malignant Tumors of the Brain
  • Malignant Tumors of the Spinal Cord
  • Meningioma
  • Metastatic Cancer
  • Oligodendroglioma
  • Pituitary Tumors
  • Sarcomas of the Brain or Head
  • Schwannoma
  • Skull Base Cancer
  • Spine Tumors

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/14/2012, Dr. Weil has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English